“My Dexcom changed my life”: Real world experiences with Dexcom G6 | Real Time Real Talk

In this podcast episode, our host Cher Pastore sat down with Matthew Vogel and Jami Klein – Dexcom employees and Dexcom users. Jami is a nurse and a Certified Diabetes Care and Education Specialist. She has been living with Type 1 diabetes since 1988. Matt is a Senior Director of Marketing, focusing on Strategic Partnerships, working with insulin pump and pen integration companies, as well as Digital Health partners. Matt is also living with Type 1 diabetes. They share their personal experiences living with diabetes, their experiences using Dexcom connected devices, and how RT-CGM has improved their lives! Dexcom, Inc. empowers people to take control of diabetes through innovative continuous glucose monitoring (CGM) systems. Headquartered in San Diego, California, Dexcom has emerged as a leader of diabetes care technology. By listening to the needs of users, caregivers, and providers, Dexcom simplifies and improves diabetes management around the world. Disclaimer: This podcast is not approved for CME credit. Every diabetes treatment plan is different, individual results may vary – nothing you hear on this podcast should be considered medical advice. All claims are supported by clinical evidence referenced in the show notes. For clinical study results, please refer to Dexcom G6 User Guide. For product-related questions, please refer to instructions for use. For complete safety information, go to dexcom.com/safety-information Smart devices are sold separately. For a list of compatible smart device visit Dexcom.com/compatibility Fingersticks required for diabetes treatment decisions if symptoms or expectations do not match readings. Data from collaborator devices and products must be verified by those collaborator devices and products. Users should confirm data and connections with their collaborator devices and products. The Dexcom G6 Continuous Glucose Monitoring System (Dexcom G6 System) is a real time, continuous glucose monitoring device indicated for the management of diabetes in persons aged 2 years and older. Learn more about your ad choices. Visit megaphone.fm/adchoices